NO903389D0 - Fremgangsmaate for fremstilling av 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-oner, samt anvendelse som medikamenter. - Google Patents
Fremgangsmaate for fremstilling av 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-oner, samt anvendelse som medikamenter.Info
- Publication number
- NO903389D0 NO903389D0 NO903389A NO903389A NO903389D0 NO 903389 D0 NO903389 D0 NO 903389D0 NO 903389 A NO903389 A NO 903389A NO 903389 A NO903389 A NO 903389A NO 903389 D0 NO903389 D0 NO 903389D0
- Authority
- NO
- Norway
- Prior art keywords
- pyridinylamino
- indol
- dihydro
- preparation
- loweralkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/388,437 US5006537A (en) | 1989-08-02 | 1989-08-02 | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
| US07/535,640 US5053511A (en) | 1989-08-02 | 1990-06-11 | 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-ones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO903389D0 true NO903389D0 (no) | 1990-08-01 |
| NO903389L NO903389L (no) | 1991-02-04 |
Family
ID=27012314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90903389A NO903389L (no) | 1989-08-02 | 1990-08-01 | Fremgangsmaate for fremstilling av 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-oner, samt anvendelse som medikamenter. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US5006537A (no) |
| EP (1) | EP0415102B1 (no) |
| JP (1) | JPH0674265B2 (no) |
| KR (2) | KR0169108B1 (no) |
| AT (1) | ATE118001T1 (no) |
| AU (2) | AU628202B2 (no) |
| CA (1) | CA2022486C (no) |
| DE (1) | DE69016530T2 (no) |
| DK (1) | DK0415102T3 (no) |
| ES (1) | ES2068293T3 (no) |
| FI (1) | FI903819A0 (no) |
| GR (1) | GR3015227T3 (no) |
| IE (1) | IE67045B1 (no) |
| IL (1) | IL95252A0 (no) |
| NO (1) | NO903389L (no) |
| NZ (1) | NZ234725A (no) |
| PT (1) | PT94879B (no) |
| ZA (1) | ZA906050B (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4868190A (en) * | 1988-12-27 | 1989-09-19 | Hoechst-Roussel Pharmaceuticals, Inc. | N-pyridinyl-9H-carbazol-9-amines |
| US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
| US5296488A (en) * | 1989-08-02 | 1994-03-22 | Hoechst-Roussel Pharmaceuticals Inc. | Method of using 2,3-dihydro-1-(pyridinylamino)-indoles as anticonvulsants and for the enhancement of memory |
| US4914102A (en) * | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
| US5076835A (en) * | 1990-05-31 | 1991-12-31 | America Cyanamid Company | Aryloxyspiroalkylindolinone herbicides |
| US5102891A (en) * | 1990-07-23 | 1992-04-07 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates |
| US5264442A (en) * | 1990-08-13 | 1993-11-23 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs |
| US5214038A (en) * | 1991-04-15 | 1993-05-25 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof |
| US5185350A (en) * | 1991-09-23 | 1993-02-09 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles |
| US5246947A (en) * | 1991-09-23 | 1993-09-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1,2-benzisothiazoles and their use for treating depression |
| ES2100523T3 (es) * | 1992-01-16 | 1997-06-16 | Du Pont Merck Pharma | Nuevos liberadores de neurotransmisores utiles para la potenciacion de las facultades cognoscitivas. |
| RU2051151C1 (ru) * | 1992-01-16 | 1995-12-27 | Дзе Дюпон Мерк Фармасьютикал Компани | Азотсодержащие гетероциклические производные флуорена |
| US5278162A (en) * | 1992-09-18 | 1994-01-11 | The Du Pont Merck Pharmaceutical Company | 3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man |
| US5296478A (en) * | 1992-10-07 | 1994-03-22 | The Dupont Merck Pharmaceutical Co. | 1-substituted oxindoles as cognition enhancers |
| FR2708606B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. |
| CA2188427C (en) * | 1994-04-29 | 2000-06-27 | Robert A. Volkmann | Neurotransmitter release enhancers |
| US5776955A (en) * | 1995-07-27 | 1998-07-07 | Hoechst Marion Roussel, Inc. | Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents |
| US6100276A (en) * | 1996-04-12 | 2000-08-08 | Aventis Pharmaceuticals Inc. | Isatin derivatives as acetylcholinesterase inhibitors and analgesics |
| ATE207483T1 (de) * | 1996-04-12 | 2001-11-15 | Aventis Pharma Inc | Isatinderivate als acetylcholinesterase- inhibitoren und analgetika |
| AU720466B2 (en) * | 1996-12-27 | 2000-06-01 | Hoechst Marion Roussel, Inc. | N-(pyridinylamino)isoindolines and related compounds |
| KR100507145B1 (ko) * | 2002-06-20 | 2005-08-09 | 현대자동차주식회사 | 차량의 전원제어장치 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4260767A (en) * | 1979-12-26 | 1981-04-07 | American Cyanamid Company | 2-Pyridylhydrazides |
| US4569942A (en) * | 1984-05-04 | 1986-02-11 | Pfizer Inc. | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
| ES2065324T3 (es) * | 1987-04-24 | 1995-02-16 | Hoechst Roussel Pharma | N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos. |
| US4983615A (en) * | 1989-06-28 | 1991-01-08 | Hoechst-Roussel Pharmaceuticals Inc. | Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders |
| US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
-
1989
- 1989-08-02 US US07/388,437 patent/US5006537A/en not_active Expired - Lifetime
-
1990
- 1990-06-11 US US07/535,640 patent/US5053511A/en not_active Expired - Lifetime
- 1990-07-31 DK DK90114660.5T patent/DK0415102T3/da active
- 1990-07-31 EP EP90114660A patent/EP0415102B1/en not_active Expired - Lifetime
- 1990-07-31 ES ES90114660T patent/ES2068293T3/es not_active Expired - Lifetime
- 1990-07-31 NZ NZ234725A patent/NZ234725A/xx unknown
- 1990-07-31 AT AT90114660T patent/ATE118001T1/de not_active IP Right Cessation
- 1990-07-31 DE DE69016530T patent/DE69016530T2/de not_active Expired - Lifetime
- 1990-07-31 FI FI903819A patent/FI903819A0/fi not_active Application Discontinuation
- 1990-07-31 IL IL95252A patent/IL95252A0/xx active IP Right Grant
- 1990-08-01 AU AU60004/90A patent/AU628202B2/en not_active Ceased
- 1990-08-01 PT PT94879A patent/PT94879B/pt not_active IP Right Cessation
- 1990-08-01 ZA ZA906050A patent/ZA906050B/xx unknown
- 1990-08-01 NO NO90903389A patent/NO903389L/no unknown
- 1990-08-01 JP JP2202618A patent/JPH0674265B2/ja not_active Expired - Lifetime
- 1990-08-01 CA CA002022486A patent/CA2022486C/en not_active Expired - Lifetime
- 1990-08-01 KR KR1019900011818A patent/KR0169108B1/ko not_active IP Right Cessation
- 1990-08-01 IE IE278790A patent/IE67045B1/en not_active IP Right Cessation
-
1992
- 1992-07-14 AU AU19630/92A patent/AU641595B2/en not_active Expired - Fee Related
-
1995
- 1995-02-28 GR GR950400432T patent/GR3015227T3/el unknown
-
1998
- 1998-06-26 KR KR1019980024262A patent/KR0175639B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE67045B1 (en) | 1996-02-21 |
| KR910004599A (ko) | 1991-03-29 |
| NO903389L (no) | 1991-02-04 |
| AU641595B2 (en) | 1993-09-23 |
| AU6000490A (en) | 1991-02-07 |
| US5053511A (en) | 1991-10-01 |
| ZA906050B (en) | 1991-05-29 |
| EP0415102A1 (en) | 1991-03-06 |
| CA2022486C (en) | 2001-04-03 |
| AU1963092A (en) | 1992-10-01 |
| AU628202B2 (en) | 1992-09-10 |
| CA2022486A1 (en) | 1991-02-03 |
| ATE118001T1 (de) | 1995-02-15 |
| US5006537A (en) | 1991-04-09 |
| DE69016530D1 (de) | 1995-03-16 |
| PT94879A (pt) | 1991-04-18 |
| FI903819A0 (fi) | 1990-07-31 |
| JPH03118377A (ja) | 1991-05-20 |
| NZ234725A (en) | 1992-12-23 |
| GR3015227T3 (en) | 1995-05-31 |
| EP0415102B1 (en) | 1995-02-01 |
| DK0415102T3 (da) | 1995-06-19 |
| JPH0674265B2 (ja) | 1994-09-21 |
| IE902787A1 (en) | 1991-02-27 |
| KR0169108B1 (ko) | 1999-01-15 |
| ES2068293T3 (es) | 1995-04-16 |
| IL95252A0 (en) | 1991-06-10 |
| PT94879B (pt) | 1997-08-29 |
| KR0175639B1 (en) | 1999-10-01 |
| DE69016530T2 (de) | 1995-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO903389D0 (no) | Fremgangsmaate for fremstilling av 1,3-dihydro-1-(pyridinylamino)-2h-indol-2-oner, samt anvendelse som medikamenter. | |
| ZA907033B (en) | N-substituted-4-pyrimidinamines an pyrimidindiamines,a process for their preparation and their use as medicaments | |
| NO903388D0 (no) | Fremgangsmaate for fremstilling av 1-(pyridinylamino)-2-pyrrolidinoner, samt anvendelse som medikamenter. | |
| AU628201B2 (en) | 2,3-dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments | |
| PT92234A (pt) | Processo para a preparacao de 1,2,3,4-tetraidro-1,9-acridinodiaminas |